week: 1, 1/6/2020 p1 grid final · scelsi, c) 5219: fate of tablet / capsule upon oral administr...

16
MONDAY Biochem 2 5117 8:55 - 9:50 Salk 456 1/6/2020 MONDAY A& P 5115 10 - 10:50 Salk 456 1/6/2020 P1 Grid Final Week: 1, 1/6/2020 WEDS Biochem 2 5117 9 - 9:50 Salk 456 1/8/2020 WEDS A&P 5115 10 - 10:50 Salk 456 1/8/2020 MONDAY Dose Form 5219 1 - 5:50 See Schedule 1/6/2020 TUESDAY C Health 2 5113 1 - 5:00 See Schedule 1/7/2020 THURS Biochem2 5117 9 - 9:50 Salk 456 1/9/2020 THURS A&P 5115 10 - 10:50 Salk 456 1/9/2020 THURS Dose Form 5219 11 - 11:50 Salk 456 1/9/2020 FRIDAY P Pat Care 2 5111 9:00 - 9:50 Salk 402 1/10/2020 FRIDAY Case Conf 5121 Salk 402 1/10/2020 THURS 5113 or 5219 1 - 6 See Schedule 1/9/2020 THURS P Pat Care 2 5111 8 - 8:50 Salk 456 1/9/2020 TUESDAY P Pat Care 2 5111 9 - 11:50 Salk 402 1/7/2020 MONDAY Dose Form 5219 11 - 11:50 Salk 456 1/6/2020 WEDS Dose Form 5219 11 - 11:50 Salk 456 1/8/2020 5117 : Biosignal ing - Introducti on to signal transduct ion (Johnsto n, P) 5115 : Introducti on to cardiova scular system 5117 : Biosignal ing II (Johnsto n, P) 5115 : Anatomy of the heart (case) 5117 : Biosignal ing III (Johnsto n, P) 5115 : Anatomy of blood vessels and cardiac cycle 5219: Dosage form design: Pharmac eutical and formulati on consider ations (Sant, V) 5111: HTN Guidelin e Practicu m and BP Training - BP CUFFS/ STETHO SCOPE S REQUIR ED (Pater, K Berenbro k, L Rebitch, C) 5121: Patient Care Docume ntation (Hall, D Farrah, R) 5113 : Debriefin g Session #1; Motivatio nal Interview ing Part I (Berenbr ok, L Connor, S) 5113 : Orientati on (Connor, S Drab, S) 5111: Introducti on to PPC2 Intro to BP Measure ment and HTN Guidelin es (Pater, K Berenbro k, L Rebitch, C) 5219: New Drug Develop ment Process (Sant, V) 5219: Dosage form design: Drug physicoc hemical propertie s and preformu lation (Sant, V) Denotes examination period Denotes professional dress required Grid Page 1

Upload: others

Post on 18-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

1/6/2020

MONDAYA& P5115

10 - 10:50

Salk 456

1/6/2020

P1 Grid FinalWeek: 1, 1/6/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

1/8/2020

WEDSA&P5115

10 - 10:50

Salk 456

1/8/2020

MONDAYDose Form

52191 - 5:50

See Schedule

1/6/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

1/7/2020

THURSBiochem2

51179 - 9:50

Salk 456

1/9/2020

THURSA&P5115

10 - 10:50

Salk 456

1/9/2020

THURSDose Form

521911 - 11:50

Salk 456

1/9/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

1/10/2020

FRIDAYCase Conf

5121

Salk 402

1/10/2020

THURS

5113 or 52191 - 6

See Schedule

1/9/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

1/9/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

1/7/2020

MONDAYDose Form

521911 - 11:50

Salk 456

1/6/2020

WEDSDose Form

521911 - 11:50

Salk 456

1/8/2020

5117 :Biosignaling -Introduction tosignaltransduction(Johnston, P)

5115 :Introduction tocardiovascularsystem

5117 :Biosignaling II(Johnston, P)

5115 :Anatomyof theheart(case)

5117 :Biosignaling III(Johnston, P)

5115 :Anatomyof bloodvesselsandcardiaccycle

5219:Dosageformdesign:Pharmaceuticalandformulationconsiderations(Sant, V)

5111:HTNGuidelinePracticum andBPTraining- BPCUFFS/STETHOSCOPESREQUIRED(Pater, KBerenbrok, LRebitch,C)

5121:PatientCareDocumentation(Hall, DFarrah,R)

5113 :DebriefingSession#1;MotivationalInterviewing Part I(Berenbrok, LConnor,S)

5113 :Orientation

(Connor,SDrab, S)

5111:Introduction toPPC2Intro toBPMeasurementand HTNGuidelines(Pater, KBerenbrok, LRebitch,C)

5219:NewDrugDevelopmentProcess(Sant, V)

5219:Dosageformdesign:Drugphysicochemicalproperties andpreformulation(Sant, V)

Denotes examination period Denotes professional dress required Grid Page 1

Thomas Waters
Note: Class is 1-4p
Thomas Waters
11:50
Page 2: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

1/13/2020

MONDAYA& P5115

10 - 10:50

Salk 456

1/13/2020

P1 Grid FinalWeek: 2, 1/13/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

1/15/2020

WEDSA&P5115

10 - 10:50

Salk 456

1/15/2020

MONDAYDose Form

52191 - 5:50

See Schedule

1/13/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

1/14/2020

THURSBiochem2

51179 - 9:50

Salk 456

1/16/2020

THURSA&P5115

10 - 10:50

Salk 456

1/16/2020

THURSDose Form

521911 - 11:50

Salk 456

1/16/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

1/17/2020

FRIDAYCase Conf

5121

Salk 402

1/17/2020

THURS

5113 or 52191 - 6

See Schedule

1/16/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

1/16/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

1/14/2020

MONDAYDose Form

521911 - 11:50

Salk 456

1/13/2020

WEDSDose Form

521911 - 11:50

Salk 456

1/15/2020

5117 :Biosginaling IV(Johnston, P)

5115 :Hemodynamics:Pressure, flowandresistance (case)

5117 :CellGrowthandFunctions(Johnston, P)

5115 :CardiacElectrophysiology

5117 :Hallmarks ofCancer(Johnston, P)

5115 :Neuralcontrol ofthecardiovaularsystem

5219:Immediate releasetablets(Sant, V)

5111:Introduction to theHealthFair

(Skledar,S)

5111:APhACareerPathways (Pater,KRebitch,C)

5111:TopDrugs 61-70(Scelsi,C)

5111:DrugInformation(Culley,CGrieve,L)

5111:Friends/FamilyCasePresentation(Pater, KRebitch,C)

5219:Compounding lab-Introduction (Sant,V)

5219:Dosageformdesign:Biopharmaceutical andpharmacokineticconsideration(Sant, V)

Denotes examination period Denotes professional dress required Grid Page 2

Thomas Waters
5115Intrinsic regulaticardiovascular sys8-8:50a402 Salk�
Thomas Waters
ColloqPortfolio Feedback and Career Plan Session1-1:50p355 Salk�
Thomas Waters
11:50
Page 3: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

1/20/2020

MONDAYA& P5115

10 - 10:50

Salk 456

1/20/2020

P1 Grid FinalWeek: 3, 1/20/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

1/22/2020

WEDSA&P5115

10 - 10:50

Salk 456

1/22/2020

MONDAYDose Form

52191 - 5:50

See Schedule

1/20/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

1/21/2020

THURSBiochem2

51179 - 9:50

Salk 456

1/23/2020

THURSA&P5115

10 - 10:50

Salk 456

1/23/2020

THURSDose Form

521911 - 11:50

Salk 456

1/23/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

1/24/2020

FRIDAYCase Conf

5121

Salk 402

1/24/2020

THURS

5113 or 52191 - 6

See Schedule

1/23/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

1/23/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

1/21/2020

MONDAYDose Form

521911 - 11:50

Salk 456

1/20/2020

WEDSDose Form

521911 - 11:50

Salk 456

1/22/2020

5117 :DNAInformation &Technology (Li, S)

5117 :DNAInformation &Technology (Li, S)

5115 :Renalanatomy,functionandphysiology I

5219:Importance ofpowderproperties intabletsandcapsules(Sant, V)

5111:CommonIssues toConsiderwithGeriatricPatients(Scelsi,C)

5121:PatientCase/BloodPressureExam(SplitClassseeseparateschedule)(Farrah,RHall, D)

5111:TopDrugs 71-80(Scelsi,C)

5113 :DebriefingSession#2;MotivationalInterviewing PartII(Berenbrok, LConnor,S)

5219:Oralroute:Capsules (Sant,V)

Denotes examination period Denotes professional dress required Grid Page 3

Thomas Waters
ColloqCo-Curriculum and the Proper Use of Evidence Session n1-1:50p355 Salk�
Thomas Waters
5111ExamBP EXAM as a part of CASE CONF12:30-4P810B�
Thomas Waters
5115ExamExam 1: Covers January 6 ‐ 17�
Thomas Waters
11:50
Page 4: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

1/27/2020

MONDAYA& P5115

10 - 10:50

Salk 456

1/27/2020

P1 Grid FinalWeek: 4, 1/27/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

1/29/2020

WEDSA&P5115

10 - 10:50

Salk 456

1/29/2020

MONDAYDose Form

52191 - 5:50

See Schedule

1/27/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

1/28/2020

THURSBiochem2

51179 - 9:50

Salk 456

1/30/2020

THURSA&P5115

10 - 10:50

Salk 456

1/30/2020

THURSDose Form

521911 - 11:50

Salk 456

1/30/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

1/31/2020

FRIDAYCase Conf

5121

Salk 402

1/31/2020

THURS

5113 or 52191 - 6

See Schedule

1/30/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

1/30/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

1/28/2020

MONDAYDose Form

521911 - 11:50

Salk 456

1/27/2020

WEDSDose Form

521911 - 11:50

Salk 456

1/29/2020

5117 :Pharmacogenetics(Empey,P)

5115 :Renalanatomy,functionandphysiology II

5117 :DNAInformation &Technology (Li, S)

5115 :Reninangiotensinaldosteronesystem(RAAS)(case)

5219:Capsules lab -Group A& B, 2sessions(Sant, V)

5117 :DNAInformation &Technology (Li, S)

5115 :Regulation ofsodium,chlorideandwater I

5219:ModifiedReleasedosageforms:Matrixandmulti-unitsystems(Sant, V)

5111:Introduction toCounseling forNew Rx

Introduction toSilverScriptsandTransitions ofCare

5219:Capsules lab,Group Cand D, 2sessions(Sant, V)

5111:Exam#1

5111:HealthFairPlanning#1(Skledar,S)

5111:BrownBagPracticum(Rebitch,CPater, KScelsi,C)

5219:Fate oftablet /capsuleuponoraladministration(Sant, V)

5219:ModifiedReleasedosageforms:Needanddesignconsiderations(Sant, V)

Denotes examination period Denotes professional dress required Grid Page 4

Thomas Waters
11:50
Page 5: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

2/3/2020

MONDAYA& P5115

10 - 10:50

Salk 456

2/3/2020

P1 Grid FinalWeek: 5, 2/3/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

2/5/2020

WEDSA&P5115

10 - 10:50

Salk 456

2/5/2020

MONDAYDose Form

52191 - 5:50

See Schedule

2/3/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

2/4/2020

THURSBiochem2

51179 - 9:50

Salk 456

2/6/2020

THURSA&P5115

10 - 10:50

Salk 456

2/6/2020

THURSDose Form

521911 - 11:50

Salk 456

2/6/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

2/7/2020

FRIDAYCase Conf

5121

Salk 402

2/7/2020

THURS

5113 or 52191 - 6

See Schedule

2/6/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

2/6/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

2/4/2020

MONDAYDose Form

521911 - 11:50

Salk 456

2/3/2020

WEDSDose Form

521911 - 11:50

Salk 456

2/5/2020

5117 :DNAInformation &Technology (Li, S)

5115 :Regulation ofsodium,chlorideandwater II

5117 :EXAM#1Lectures1-12(Johnston, PLi, S)

5115 :Regulation ofpotassium (case)

5117 :Bioenergetics &Metabolism(McDermott, L)

5115 :Regulation ofcalciumandphophate

5219:Solutions, syrupsandelixirs(Sant, V)

5121:StandardizedPatientActivitySeePharmacistPatientCareSchedule(Berenbrok, LHall, DFarrah,R)

5111:TopDrugs 81-90

5111: Dr.Pater’sFriendsandFamilySPLITCLASSBETWEEN 402and 5249-10.30Groups 1-1010.30 -NoonGroups11-20

HEALTHFAIRPLANNINGSESSION #2

5219:ModifiedReleasedosageforms:Osmoticandentericsystems(Sant, V)

5219:Solutions: factorsaffectingdrugsolubility(Sant, V)

Denotes examination period Denotes professional dress required Grid Page 5

Thomas Waters
5219Practicum 1All Groups3:30-5P402 Salk⺀
Thomas Waters
11:50
Page 6: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

2/10/2020

MONDAYA& P5115

10 - 10:50

Salk 456

2/10/2020

P1 Grid FinalWeek: 6, 2/10/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

2/12/2020

WEDSA&P5115

10 - 10:50

Salk 456

2/12/2020

MONDAYDose Form

52191 - 5:50

See Schedule

2/10/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

2/11/2020

THURSBiochem2

51179 - 9:50

Salk 456

2/13/2020

THURSA&P5115

10 - 10:50

Salk 456

2/13/2020

THURSDose Form

521911 - 11:50

Salk 456

2/13/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

2/14/2020

FRIDAYCase Conf

5121

Salk 402

2/14/2020

THURS

5113 or 52191 - 6

See Schedule

2/13/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

2/13/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

2/11/2020

MONDAYDose Form

521911 - 11:50

Salk 456

2/10/2020

WEDSDose Form

521911 - 11:50

Salk 456

2/12/2020

5117 :CitricAcidCycle(McDermott, L)

5115 :Acid-basebalance

5117 :CitricAcidCycle(McDermott, L)

5219:Trocheandmedication stickslab(Group Aand B)(Sant, V)

5117 :FattyAcidCatabolism(McDermott, L)

5115 :Functionalanatomyofrespiratorysystem I

5219:Suspensions(Sant, V)

5121:PatientCaseActivity(Hall, DFarrah,R)

5219:Trocheandmedication stickslab(Group Cand D)(Sant, V)

5111:TopDrugs 91-100

5113 :DebriefingSession#3;CulturalSensitivityEthicalandSocietalProblems: ImpactofCulture(Connor,SKo, JDrab, S)

5219:Exam -1(Contenttill 6thFeb)(Sant, V)

5219:Dispersesystems:sedimentationtheoryandsurfactants (Sant,V)

Denotes examination period Denotes professional dress required Grid Page 6

Thomas Waters
5115EXAM 2: Covers Jan 23 - Feb 10�
Thomas Waters
11:50
Page 7: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

2/17/2020

MONDAYA& P5115

10 - 10:50

Salk 456

2/17/2020

P1 Grid FinalWeek: 7, 2/17/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

2/19/2020

WEDSA&P5115

10 - 10:50

Salk 456

2/19/2020

MONDAYDose Form

52191 - 5:50

See Schedule

2/17/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

2/18/2020

THURSBiochem2

51179 - 9:50

Salk 456

2/20/2020

THURSA&P5115

10 - 10:50

Salk 456

2/20/2020

THURSDose Form

521911 - 11:50

Salk 456

2/20/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

2/21/2020

FRIDAYCase Conf

5121

Salk 402

2/21/2020

THURS

5113 or 52191 - 6

See Schedule

2/20/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

2/20/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

2/18/2020

MONDAYDose Form

521911 - 11:50

Salk 456

2/17/2020

WEDSDose Form

521911 - 11:50

Salk 456

2/19/2020

5117 :FattyAcidCatabolism(McDermott, L)

5115 :Functionalanatomyofrespiratorysystem II(case/quiz)

5117 :AminoAcidOxidation & Urea(McDermott, L)

5115 :Mechanics ofbreathing

5219:Solutions,suspensions andemulsions lab(Group Aand B)(Sant, V)

5117 :AminoAcidOxidation & Urea(McDermott, L)

5115 :Transport ofoxygenandcarbondioxide

5219:Formulations forwomenhealthissues-Films &gels(Rohan,L)

5111:TEAM -BASEDLearning

5219:Solutions,suspensions andemulsions lab(Group Cand D)(Sant, V)

5111:EXAM#2

5111: SPPracticePracticumGroups 1-10(Pater,K)

5111:HealthFairPlanningSession#3Groups11-20(Skledar,S)

5219:Emulsions (Sant,V)

5219:RectalRoute:Gels,suppositories,enema(Rohan,L)

Denotes examination period Denotes professional dress required Grid Page 7

Thomas Waters
11:50
Page 8: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

2/24/2020

MONDAYA& P5115

10 - 10:50

Salk 456

2/24/2020

P1 Grid FinalWeek: 8, 2/24/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

2/26/2020

WEDSA&P5115

10 - 10:50

Salk 456

2/26/2020

MONDAYDose Form

52191 - 5:50

See Schedule

2/24/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

2/25/2020

THURSBiochem2

51179 - 9:50

Salk 456

2/27/2020

THURSA&P5115

10 - 10:50

Salk 456

2/27/2020

THURSDose Form

521911 - 11:50

Salk 456

2/27/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

2/28/2020

FRIDAYCase Conf

5121

Salk 402

2/28/2020

THURS

5113 or 52191 - 6

See Schedule

2/27/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

2/27/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

2/25/2020

MONDAYDose Form

521911 - 11:50

Salk 456

2/24/2020

WEDSDose Form

521911 - 11:50

Salk 456

2/26/2020

5117 :AminoAcidBiosynthesis(McDermott, L)

5115 :Controlofrespiration(case/quiz)

5117 :AminoAcidBiosynthesis(McDermott, L)

5115 :Pathophysiologyof lungdisease

5219:Suppositories lab(Group Aand B)(Sant, V)

5117 :ClassreviewLectures13-21(McDermott, L)

5115 :Lungdiseases

5219:Principles oftopicalandtransdermaldelivery(Rohan,L)

5111:TeamBasedLearning(Pater,K)

5219:Suppositories lab(Group Cand D)(Sant, V)

5111:PersonalizedLearning-Philosophy ofCare(Grieve,L)

5111: SPPRACTICEPRACTICUMGroups11 - 20(Pater,K)

5111:HealthFairPlanningSession#3Groups 1-10(Skledar,S)

5219:Formulations forwomenhealthissues-Ringsandimplants(Rohan,L)

5219:Contraceptives(Rohan,L)

Denotes examination period Denotes professional dress required Grid Page 8

Thomas Waters
5111Silverscripts9-11:50A402 and other�
Thomas Waters
11:50
Page 9: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

3/2/2020

MONDAYA& P5115

10 - 10:50

Salk 456

3/2/2020

P1 Grid FinalWeek: 9, 3/2/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

3/4/2020

WEDSA&P5115

10 - 10:50

Salk 456

3/4/2020

MONDAYDose Form

52191 - 5:50

See Schedule

3/2/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

3/3/2020

THURSBiochem2

51179 - 9:50

Salk 456

3/5/2020

THURSA&P5115

10 - 10:50

Salk 456

3/5/2020

THURSDose Form

521911 - 11:50

Salk 456

3/5/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

3/6/2020

FRIDAYCase Conf

5121

Salk 402

3/6/2020

THURS

5113 or 52191 - 6

See Schedule

3/5/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

3/5/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

3/3/2020

MONDAYDose Form

521911 - 11:50

Salk 456

3/2/2020

WEDSDose Form

521911 - 11:50

Salk 456

3/4/2020

5117 :EXAM #2Lectures13-21(McDermott, L)

5115 :Functionalanatomyof thedigestivesystem

5117 :Glycolysis/Gluconeogenesis (Ma, X)

5219:Ointments andcreamslab(Group Aand B)(Sant, V)

5117 :Glycolysis/Gluconeogenesis (Ma, X)

5115 :Mechanicalprocessesinvolvedindigestion(case/quiz)

5219:Ointments,creams,pastesandliniments(Sant, S)

5111:DrugInformation(Culley,CGrieve,L)

5219:Ointments andcreamslab(Group Cand D)(Sant, V)

5111:IPPEGROUPPRESENTATIONS #1

5219:Transdermal drugdeliverysystems(Rohan,L)

5219:TopicalRoute:Ointments bases(Sant, S)

Denotes examination period Denotes professional dress required Grid Page 9

Thomas Waters
5111Health Fair #48-8:50A402�
Thomas Waters
5115EXAM 3: Covers Feb 13 - Feb 27 �
Thomas Waters
11:50
Page 10: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

3/9/2020

MONDAYA& P5115

10 - 10:50

Salk 456

3/9/2020

P1 Grid FinalWeek: 10, 3/9/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

3/11/2020

WEDSA&P5115

10 - 10:50

Salk 456

3/11/2020

MONDAYDose Form

52191 - 5:50

See Schedule

3/9/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

3/10/2020

THURSBiochem2

51179 - 9:50

Salk 456

3/12/2020

THURSA&P5115

10 - 10:50

Salk 456

3/12/2020

THURSDose Form

521911 - 11:50

Salk 456

3/12/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

3/13/2020

FRIDAYCase Conf

5121

Salk 402

3/13/2020

THURS

5113 or 52191 - 6

See Schedule

3/12/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

3/12/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

3/10/2020

MONDAYDose Form

521911 - 11:50

Salk 456

3/9/2020

WEDSDose Form

521911 - 11:50

Salk 456

3/11/2020

Denotes examination period Denotes professional dress required Grid Page 10

Thomas Waters
Spring Break
Thomas Waters
11:50
Page 11: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

3/16/2020

MONDAYA& P5115

10 - 10:50

Salk 456

3/16/2020

P1 Grid FinalWeek: 11, 3/16/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

3/18/2020

WEDSA&P5115

10 - 10:50

Salk 456

3/18/2020

MONDAYDose Form

52191 - 5:50

See Schedule

3/16/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

3/17/2020

THURSBiochem2

51179 - 9:50

Salk 456

3/19/2020

THURSA&P5115

10 - 10:50

Salk 456

3/19/2020

THURSDose Form

521911 - 11:50

Salk 456

3/19/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

3/20/2020

FRIDAYCase Conf

5121

Salk 402

3/20/2020

THURS

5113 or 52191 - 6

See Schedule

3/19/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

3/19/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

3/17/2020

MONDAYDose Form

521911 - 11:50

Salk 456

3/16/2020

WEDSDose Form

521911 - 11:50

Salk 456

3/18/2020

5117 :Glycolysis/Gluconeogenesis (Ma, X)

5115 :Accessorydigestiveorgans

5117 :MetabolicRegulation (Ma,X)

5115 :Secretions of thedigestivesystem(case/quiz)

5117 :MetabolicRegulation (Ma,X)

5115 :Chemicalcomposition offoods,digestionandabsorption

5219:Guestlecture /Review(TBD)

5121:Out ofClassPatientCaseDue (Noin classsession)

5111:TopDrugs101-110

5113 :DebriefingSession#4;WorldsApart(Connor,SJonkman, LDrab, S)

5219:Hydrogels (Sant,S)

5219:Hydrogels -2(Sant, S)

Denotes examination period Denotes professional dress required Grid Page 11

Thomas Waters
ColloqPeer Evaluation of Portfolios1-1:50p355 Salk�
Page 12: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

3/23/2020

MONDAYA& P5115

10 - 10:50

Salk 456

3/23/2020

P1 Grid FinalWeek: 12, 3/23/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

3/25/2020

WEDSA&P5115

10 - 10:50

Salk 456

3/25/2020

MONDAYDose Form

52191 - 5:50

See Schedule

3/23/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

3/24/2020

THURSBiochem2

51179 - 9:50

Salk 456

3/26/2020

THURSA&P5115

10 - 10:50

Salk 456

3/26/2020

THURSDose Form

521911 - 11:50

Salk 456

3/26/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

3/27/2020

FRIDAYCase Conf

5121

Salk 402

3/27/2020

THURS

5113 or 52191 - 6

See Schedule

3/26/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

3/26/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

3/24/2020

MONDAYDose Form

521911 - 11:50

Salk 456

3/23/2020

WEDSDose Form

521911 - 11:50

Salk 456

3/25/2020

5117 :MetabolicRegulation (Ma,X)

5115 :Metabolism andnutrition

5117 :OxidativePhosphorylation(Ma, X)

5117 :OxidativePhosphorylation(Ma, X)

5115 :Pituitarygland I:Neurohypophysealhormones

5219:Steriledosageforms -1(Sant, V)

5219:Ophthalmic andoticpreparations lab(Group Cand D)(Sant, V)

5111:TopDrugs111-120

5111:Introduction to theHealthProfession Team

(Berenbrok, L)

5219:Exam 2(Contenttill 19Mar)(Rohan,LSant, SSant, V)

5219:Parenteral route:Principles ofsterilization (Sant,V)

Denotes examination period Denotes professional dress required Grid Page 12

Thomas Waters
5111ExamSP Final8-11:50A523�
Thomas Waters
5115EXAM 4: Covers Mar 2 - Mar 23 �
Page 13: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

3/30/2020

MONDAYA& P5115

10 - 10:50

Salk 456

3/30/2020

P1 Grid FinalWeek: 13, 3/30/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

4/1/2020

WEDSA&P5115

10 - 10:50

Salk 456

4/1/2020

MONDAYDose Form

52191 - 5:50

See Schedule

3/30/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

3/31/2020

THURSBiochem2

51179 - 9:50

Salk 456

4/2/2020

THURSA&P5115

10 - 10:50

Salk 456

4/2/2020

THURSDose Form

521911 - 11:50

Salk 456

4/2/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

4/3/2020

FRIDAYCase Conf

5121

Salk 402

4/3/2020

THURS

5113 or 52191 - 6

See Schedule

4/2/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

4/2/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

3/31/2020

MONDAYDose Form

521911 - 11:50

Salk 456

3/30/2020

WEDSDose Form

521911 - 11:50

Salk 456

4/1/2020

5117 :EXAM#3Lectures#22-29(Ma, X)

5115 :Pituitarygland II:Adenohypophysealhormones

5117 :HormonalRegulation(McDermott, L)

5115 :Thyroidgland I

5219:Ophthalmic andoticpreparations lab(Group Aand B)(Sant, V)

5117 :HormonalRegulation(McDermott, L)

5115 :Thyroidgland IIandParathyroidglands(case/quiz)

5219:Nasaldrops,gels(Sant, V)

5219:Make uplab - withpermission (Allgroups)(Sant, V)

5111:Exam #3

5111:PersonalizedLearningDiscussions -Exploring thePharmacyProfession(Pater,K)

5219:Steriledosageforms -2(Sant, V)

5219:Pulmonary andintranasal route:Aerosols(Sant, V)

Denotes examination period Denotes professional dress required Grid Page 13

Thomas Waters
5111BriefingSession8-8:50A105DavidLawrenceHallȃ
Thomas Waters
5111ExamSP Final8-11:50a523 Salk�
Page 14: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

4/6/2020

MONDAYA& P5115

10 - 10:50

Salk 456

4/6/2020

P1 Grid FinalWeek: 14, 4/6/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

4/8/2020

WEDSA&P5115

10 - 10:50

Salk 456

4/8/2020

MONDAYDose Form

52191 - 5:50

See Schedule

4/6/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

4/7/2020

THURSBiochem2

51179 - 9:50

Salk 456

4/9/2020

THURSA&P5115

10 - 10:50

Salk 456

4/9/2020

THURSDose Form

521911 - 11:50

Salk 456

4/9/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

4/10/2020

FRIDAYCase Conf

5121

Salk 402

4/10/2020

THURS

5113 or 52191 - 6

See Schedule

4/9/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

4/9/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

4/7/2020

MONDAYDose Form

521911 - 11:50

Salk 456

4/6/2020

WEDSDose Form

521911 - 11:50

Salk 456

4/8/2020

5117 :HormonalRegulation(McDermott, L)

5115 :Pancreas I:Structureandfunction

5117 :23&MeLecture(Empey,P)

5115 :Pancreas II:Dysregulation(case/quiz)

5219:Lab finalexam(Sant, V)

5117 :LipidBiosynthesis(Iyer, P)

5115 :Adrenalglands:Structureandfunction

5219:Nanocarriers(Sant, S)

5111:DrugInformation(Culley,CGrieve,L)

5111:SpecialPopulations:LBGTQHealthCare(Grieve,L)

5111:TOPDRUGS:TestyourKnowledgePracticum

5219:Principles oftargeteddrugdeliverysystems(Sant, S)

5219:Liposomes (Sant,S)

Denotes examination period Denotes professional dress required Grid Page 14

Page 15: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

4/13/2020

MONDAYA& P5115

10 - 10:50

Salk 456

4/13/2020

P1 Grid FinalWeek: 15, 4/13/2020

WEDSBiochem 2

51179 - 9:50

Salk 456

4/15/2020

WEDSA&P5115

10 - 10:50

Salk 456

4/15/2020

MONDAYDose Form

52191 - 5:50

See Schedule

4/13/2020

TUESDAYC Health 2

51131 - 5:00

See Schedule

4/14/2020

THURSBiochem2

51179 - 9:50

Salk 456

4/16/2020

THURSA&P5115

10 - 10:50

Salk 456

4/16/2020

THURSDose Form

521911 - 11:50

Salk 456

4/16/2020

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

4/17/2020

FRIDAYCase Conf

5121

Salk 402

4/17/2020

THURS

5113 or 52191 - 6

See Schedule

4/16/2020

THURSP Pat Care 2

51118 - 8:50

Salk 456

4/16/2020

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

4/14/2020

MONDAYDose Form

521911 - 11:50

Salk 456

4/13/2020

WEDSDose Form

521911 - 11:50

Salk 456

4/15/2020

5117 :LipidBiosynthesis(Iyer, P)

5115 :Reproductivesystemandhormones

5117 :NucleotideBiosynthesis(Iyer, P)

5115 :Examreviewsession(coversMar 26 -Apr 13)

5117 :NucleotideBiosynthesis(Iyer, P)

5219:Guestlecture /review

5111:IPPECASEPRESENTATIONS #2

5121:FinalPatientCaseActivity(Hall, DFarrah,R)

5111:Wrap-up:HealthFairOrientation to P2Activities

DrugInformation(Skledar,S)

5113 :DebriefingSession#5(Connor,SDrab, S)

5111:TOPDRUGS1-120REVIEW

5219:Biologics-1 (Sant,S)

5219:Biologics-2(Vaccines /regulatoryprocess)(Sant, VSant, S)

Denotes examination period Denotes professional dress required Grid Page 15

Thomas Waters
5219ExamPracticum 3All Groups4-5:30p402 Salk�
Page 16: Week: 1, 1/6/2020 P1 Grid Final · Scelsi, C) 5219: Fate of tablet / capsule upon oral administr ation (Sant, V) 5219: Modified Release dosage forms: Need and design consider ations

MONDAYBiochem 2

51178:55 - 9:50

Salk 456

MONDAYA& P5115

10 - 10:50

Salk 456

P1 Grid FinalWeek: 16,

WEDSBiochem 2

51179 - 9:50

Salk 456

WEDSA&P5115

10 - 10:50

Salk 456

MONDAYDose Form

52191 - 5:50

See Schedule

TUESDAYC Health 2

51131 - 5:00

See Schedule

THURSBiochem2

51179 - 9:50

Salk 456

THURSA&P5115

10 - 10:50

Salk 456

THURSDose Form

521911 - 11:50

Salk 456

FRIDAYP Pat Care 2

51119:00 - 9:50

Salk 402

FRIDAYCase Conf

5121

Salk 402

THURS

5113 or 52191 - 6

See Schedule

THURSP Pat Care 2

51118 - 8:50

Salk 456

TUESDAYP Pat Care 2

51119 - 11:50

Salk 402

MONDAYDose Form

521911 - 11:50

Salk 456

WEDSDose Form

521911 - 11:50

Salk 456

Denotes examination period Denotes professional dress required Grid Page 16

Thomas Waters
Final Exams